Clinical conditions and risk factors for inhibitor-development in patients with haemophilia: A decade-long prospective cohort study in Japan, J-HIS2 (Japan Hemophilia Inhibitor Study 2).
Keiji NogamiMasashi TakiTadashi MatsushitaTetsuhito KojimaToshiaki OkaShouichi OhgaKiyoshi KawakamiMichio SakaiTakashi SuzukiSatoshi HigasaYasuo HorikoshiKeiko ShinozawaShogo TamuraKoji YadaMasue ImaizumiYoshitoshi OhtsukaFuminori IwasakiMasao KobayashiJunki TakamatsuHideyuki TakedaniHisaya NakadateYoko MatsuoTakeshi MatsumotoTeruhisa FujiiKatsuyuki FukutakeAkira ShirahataAkira YoshiokaMidori Shimanull nullPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2022)
The J-HIS2 study has identified significant clinical variables associated with inhibitor-development in Japanese PwH, consistent with other global studies.
Keyphrases